Home › Medical Devices › Minimally Invasive/Non-Invasive Surgery
Minimally Invasive/Non-Invasive Surgery Market Research Reports & Consulting
Minimally invasive surgery (MIS) is considered as one of the most important developments in the healthcare industry. A number of companies, especially new entrants from developing nations, are competing to benefit from the rapid growth of this market. With cutting-edge technologies such as capsule endoscopy and drug eluting stents, the MIS market is set to evolve due to the increasing global demand for painless treatment and reduced post-operative stay. This section includes research reports on the:
∑ MIS product market (surgical devices, monitoring and visualization systems, endosurgical equipments, and electrosurgical equipment),
∑ MIS application market (gastrointestinal surgery, gynecology surgery, urology surgery, cosmetic surgery, obesity surgery, thoracic surgery, vascular surgery, orthopaedic surgery, and other surgery),
∑ MIS technology market (transcatheter surgery, laparoscopy surgery, non-visual imaging and medical robotics),
∑ MIS end-user market (hospital surgical departments, outpatient surgery centers, group practices, individual surgeons, medical schools, and other users). see less
Minimally invasive surgery (MIS) is considered as one of the most important developments in the healthcare industry. A number of companies, especially new entrants from developing nations, are competing to benefit from the rapid growth of this market. With cutting-edge technologies such as capsu ....see more
Tumor Ablation Market by Technology (Radiofrequency, Microwave, Cryoablation, IRE, Ultrasound, Laser), Mode of Treatment (Surgical, Laparoscopic, Percutaneous), Application (Liver, Lung, Kidney, Bone Metastasis, Prostate, Breast) - Global Forecast 2021
The global tumor ablation market is expected to reach a value of USD 580.1 Million by 2021, at a CAGR of 12.5% during 2016-2021. A number of factors such as technological advancements in the field of tumor ablation focused on enhancing effectiveness and safety of the treatment, rising demand of minimal invasive tumor ablation techniques, increasing prevalence of cancer across the globe, and growing public-private initiatives and funding to support R&D activities in tumor ablation are propelling the growth of the market. However, factors such as unfavorable regulatory policies and cost-containment measures adopted by various governments are restraining the optimal market growth.
|October 2016||$ 5650|
Bioabsorbable Stents Market by Material (Polymer, Metal), Procedure (Invasive), Absorption Rate (Slow, Fast), Drugs (Limus drugs, Paclitaxel), Application (CAD, PAD), End User (Hospital, Cardiac Centers) - Global Forecast to 2021
The global bioabsorbable stents market is expected to reach USD 2.4 Billion by 2021 from USD 0.4 Billion by 2016, at a CAGR of 42.5% during the forecast period. The major driving factors are the increasing focus of the companies on clinical trials of bioabsorbable stents, increasing aging population, technological advancements, and patientsí preference for minimally invasive therapies. However, factors such as the high prices of these stents may hamper the growth of the market.
|June 2016||$ 5650|
Varicose Vein Treatment Market in North America and Europe by Treatment Mode (Endovenous Ablation, Sclerotherapy, Stripping), Products (Laser & RF Ablation, Venous Closure, Surgical) - Forecasts to 2021
The varicose vein treatment market in North America and Europe is expected to reach USD 289.7 Million by 2021 from USD 207.9 Million in 2016, at a CAGR of 6.9% between 2016 and 2021. The swollen, twisted veins that are visible under the skin are termed as varicose veins.
|May 2016||$ 5650|
Minimally Invasive Medical Robotics, Imaging & Visualization Systems & Surgical Instruments Market Forecasts to 2016 (DA VINCI, Robodoc, Spine Assist, Neuromate, Ultrasound, CT, MRI, X-RAY Imaging, Electrosurgical Devices, Handheld Instruments, Guiding Devices, Inflation Systems & Auxiliary Devices) Global Trends & Competitive Analysis
A minimally invasive surgical (MIS) procedure refers to the surgery performed with minute incisions in the body; for instance, plaque blockages in the arteries of the heart and other vessel walls of peripheral organs, such as lower extremities, neck, kidneys, and brain. The principal advantage of these procedures over surgery is short recovery time, small scars, low risk of infection, less bleeding, and shorter hospital stays.
|July 2012||$ 5650|
The global minimally invasive surgery market is witnessing steady growth due to rapid technological advancements changing demographics and rising awareness amongst the patient population for less invasive procedures or single incision procedures.
|October 2010||$ 5650|
This report will analyze the market potential for minimally invasive/non-invasive surgery. The target segment (end-users) of the minimal invasive/non-invasive surgery products are mainly hospital surgical departments, outpatient surgery centers, group medical practices, individual surgeons, and medical schools. The number of outpatient centers is set to rise, as a low cost alternative for hospitals.
|July 2009||$ 5650|